263 related articles for article (PubMed ID: 16625226)
1. Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS.
Ramanathan R
J Perinatol; 2006 May; 26 Suppl 1(Suppl 1):S51-6; discussion S63-4. PubMed ID: 16625226
[TBL] [Abstract][Full Text] [Related]
2. Choosing a right surfactant for respiratory distress syndrome treatment.
Ramanathan R
Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
[TBL] [Abstract][Full Text] [Related]
3. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
Fujii A; Allen R; Doros G; O'Brien S
J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
[TBL] [Abstract][Full Text] [Related]
4. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S
J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076
[TBL] [Abstract][Full Text] [Related]
5. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Harrington EW; Blennow M; Soll RF
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
[TBL] [Abstract][Full Text] [Related]
6. Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome.
Kadıoğlu Şimşek G; Kanmaz Kutman HG; Canpolat FE; Oğuz ŞS
Clin Respir J; 2020 Mar; 14(3):285-290. PubMed ID: 31814293
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
Jeon GW; Oh M; Sin JB
Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
9. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
10. Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.
Terek D; Gonulal D; Koroglu OA; Yalaz M; Akisu M; Kultursay N
Pediatr Neonatol; 2015 Aug; 56(4):248-55. PubMed ID: 25603725
[TBL] [Abstract][Full Text] [Related]
11. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
Dizdar EA; Sari FN; Aydemir C; Oguz SS; Erdeve O; Uras N; Dilmen U
Am J Perinatol; 2012 Feb; 29(2):95-100. PubMed ID: 22105435
[TBL] [Abstract][Full Text] [Related]
13. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll RF; Wiswell T
Cochrane Database Syst Rev; 2007 Oct; (4):CD006069. PubMed ID: 17943881
[TBL] [Abstract][Full Text] [Related]
14. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.
Singh N; Halliday HL; Stevens TP; Suresh G; Soll R; Rojas-Reyes MX
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010249. PubMed ID: 26690260
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial.
Ramanathan R; Biniwale M; Sekar K; Hanna N; Golombek S; Bhatia J; Naylor M; Fabbri L; Varoli G; Santoro D; Del Buono D; Piccinno A; Dammann CE
J Pediatr; 2020 Oct; 225():90-96.e1. PubMed ID: 32553868
[TBL] [Abstract][Full Text] [Related]
16. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll RF; Wiswell T
Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
[TBL] [Abstract][Full Text] [Related]
17. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.
Dargaville PA; Kamlin CO; De Paoli AG; Carlin JB; Orsini F; Soll RF; Davis PG
BMC Pediatr; 2014 Aug; 14():213. PubMed ID: 25164872
[TBL] [Abstract][Full Text] [Related]
18. Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: a retrospective cohort study.
Paul S; Rao S; Kohan R; McMichael J; French N; Zhang G; Simmer K
J Paediatr Child Health; 2013 Oct; 49(10):839-44. PubMed ID: 23802801
[TBL] [Abstract][Full Text] [Related]
19. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
Ramanathan R; Rasmussen MR; Gerstmann DR; Finer N; Sekar K;
Am J Perinatol; 2004 Apr; 21(3):109-19. PubMed ID: 15085492
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
